BioHealth News Archive
Insilico Medicine receives strategic investment from Chinese biotech firm – Technical.ly Baltimore
Baltimore-based Insilico Medicine landed a new strategic investment from Chinese biotech company WuXi AppTec. The amount of the funding was not disclosed, but the…
Read More
Top 10 Under 40 – The Lists – GEN
If indeed “innovation distinguishes between a leader and a follower,” as Steve Jobs wrote in 2001, then this year’s Top 10 Under 40 are…
Read More
United Therapeutics (UTHR) Announces Collaboration with XVIVO Perfusion to Reduce Organ Shortage
United Therapeutics Corporation (NASDAQ: UTHR) and XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), today announced that the use of XVIVO's…
Read More
CRISPR Could Help Us Cure Diseases. It Could Also Cause Cancer.
You know already about the promise for CRISPR-Cas9 — it might revolutionize fields from medicine to agriculture. It might also eventually cause tumors. {iframe}https://futurism.com/crispr-cancer-p53/{/iframe}
Read More
Next Chapter For Biotech? Many Say ‘Convergence’ With Data Science | CommonHealth
So far, the digital revolution has mostly been a disappointment in health care. Doctors stare at their screens instead of us. Specialists and emergency…
Read More
Neuralstem Awarded Phase I SBIR Contract to Support Research into Neural Stem Cell Therapy for Severe Traumatic Brain Injury Nasdaq:CUR
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has been awarded a Phase I Small…
Read More
TEDCO launching fund to serve the young startups venture capitalists often overlook – Baltimore Business Journal
Maryland Technology Development Corp. is launching a new fund that will offer early stage investments of $50,000 to startups that may be overlooked by…
Read More
Gates Foundation debuts nonprofit biotech firm at BIO – MedCity News
Biotechnology is one of the hottest areas in business and investing, so it might seem a bit counterintuitive that a new biotechnology firm just…
Read More
Eight startups join Maryland duo-backed accelerator · Articles · Global University Venturing
Eight US-based startups have been accepted onto the 2018 cohort of Trajectory Next, a second-stage accelerator run by Johns Hopkins University (JHU), University of…
Read More
Gottlieb at BIO: FDA developing processes around right-to-try law – MedCity News
Perhaps it was inevitable that with Food and Drug Administration Commissioner Scott Gottlieb speaking before an auditorium full of biotechnology executives, a particularly contentious…
Read More
Lockheed Martin Doubles Venture Capital Fund To $200 Million – Defense Daily Network
Lockheed Martin [LMT] on Wednesday said it has added another $100 million to its venture capital fund, doubling the firepower of Lockheed Martin Ventures…
Read More
Life sciences companies could see changes in collaborations with new accounting standard – Boston Business Journal
Regulatory and competitive uncertainties in the marketplace lead many life sciences companies to enter into collaborative arrangements with other companies to develop new drugs…
Read More
Johns Hopkins, Betamore, UMB select a cohort of startups for Baltimore’s newest accelerator program Trajectory Next – Baltimore Business Journal
Betamore, Johns Hopkins Technology Ventures and the University of Maryland, Baltimore have launched the first cohort of a new collaborative accelerator program, called Trajectory…
Read More
GlycoMimetics prices $119m public offering – MassDevice
GlycoMimetics (NSDQ:GLYC) priced an underwritten public offering of 7,000,000 shares of common stock at $17.00 apiece today, reporting that it expects to bring in $119…
Read More
Emergent BioSolutions Announces $50 Million Expansion of Baltimore Fill/Finish Facility NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today announced the beginning of a $50 million expansion to the company’s Camden fill/finish facility located in Baltimore, Md. The…
Read More